Ticker: CO, Company: China Cord Blood Corp, Type: 20-F, Date: 2011-09-28
Original SEC Filing: Click here

---

Webplus: CO/20110928/20-F_1/1/000.htm SEC Original: v233979_20f.htm
FORM 20-F ¨ OR x For the fiscal year ended March 31, 2011. OR ¨ OR ¨ Date of event requiring this shell company report: For the transition period from ________ to ________ China Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albert Chen +852

---

---

Webplus: CO/20110928/20-F_1/2_EX-4.5/000.htm SEC Original: v233979_ex4-5.htm
Summary of Loan Agreement Agreement #[ ] Party A (Borrower): Beijing Jiachenhong Biological Technologies, Co., Ltd. Party B (Lender): Huaxia Bank, Beijing Xiushui Branch Article 1 Type of Loan Working Capital Loan Article 2 Amount and Currency of Loan 2.1 The currency of the loan stipulated in the agreement is Renminbi (“RMB”). 2.2 The amount of the loan under this

---

---

Webplus: CO/20110928/20-F_1/3_EX-4.10/000.htm SEC Original: v233979_ex4-10.htm
CordLife (Hong Kong) Ltd and China Cord Blood Corporation Marketing Collaboration Agreement This Marketing Collaboration Agreement (“Agreement”) is dated the date specified on the execution page of this Agreement. CordLife (Hong Kong) Ltd (“CordLife HK”), 31006823 AND China Cord Blood Corporation (“CCBC”), WHEREAS A. CordLife HK offers services of cord blood stem cell collection, processing, testing and storage services to

---

---

Webplus: CO/20110928/20-F_1/4_EX-8.1/000.htm SEC Original: v233979_ex8-1.htm
List of Subsidiaries Name Jurisdiction China Cord Blood Services Corporation Cayman Islands China Stem Cells Holdings Limited Cayman Islands Beijing Jiachenhong Biological Technologies Co., Limited People’s Republic of China China Stem Cells (South) Company Limited British Virgin Islands Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd. People’s Republic of China China Stem Cells (East) Company Limited China Stem Cells (East) Company

---

---

Webplus: CO/20110928/20-F_1/5_EX-12.1/000.htm SEC Original: v233979_ex12-1.htm
Certification I, Ting Zheng, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements

---

---

Webplus: CO/20110928/20-F_1/6_EX-12.2/000.htm SEC Original: v233979_ex12-2.htm
Certification I, Albert Chen, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements

---

---

Webplus: CO/20110928/20-F_1/7_EX-13.1/000.htm SEC Original: v233979_ex13-1.htm
Certification CHINA CORD BLOOD CORPORATION September 28, 2011 Ting Zheng Chief Executive Officer September 28, 2011 Albert Chen Chief Financial Officer (Principal Financial and Accounting Officer)

---

---

Webplus: CO/20110928/20-F_1/8_EX-15.1/000.htm SEC Original: v233979_ex15-1.htm
Consent of Independent Registered Public Accounting Firm The Board of Directors China Cord Blood Corporation: Our report dated September 27, 2011 on the consolidated financial statements contains an explanatory paragraph that states the Company completed a share exchange with China Cord Blood Services Corporation (“CCBS”) on June 30, 2009 and the share exchange has been accounted for financial reporting purposes

---

Company Information:

Ticker: CO, Company: China Cord Blood Corp, Type: 20-F, Date: 2011-09-28CIK: 0001467808, Location: K3, SIC: 6770, SIC Desc: BLANK CHECKS
Business Phone & Address:
48 FL., BANK OF CHINA TOWER, 1 GARDEN ROAD
CENTRAL HONG KONG, K3 000000